| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.35 | 5e-06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 0.0003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.001 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.001 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |